474. A New cGMP Facility to Produce Clinical Grade Batches of Lentiviral Vectors and CAR-T Cell in Europe

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)34083-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

671. Development of a Successful Lyophilization Process for Lentiviral Vector Clinical Batches

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

The EURE-CART Project as a Prototype Model for CAR T-Cell Immunotherapy in Europe

European Journal of Immunology
AllergyImmunology
2018English

Persistence of Integrase-Deficient Lentiviral Vectors Correlates With the Induction of STING-Independent CD8+ T Cell Responses

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

Approaches to Sensitizing Glioblastoma to Radiotherapy: Use of Lentiviral Vectors

International Journal of Oncology
Cancer ResearchOncology
2012English

547. A Simple and Scalable Method to Concentrate Measles-Pseudotyped Lentiviral Vectors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

PostexitSurface Engineering of Retroviral/Lentiviral Vectors

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Clinical Trials of Dual-Target CAR T Cells, Donor-Derived CAR T Cells, and Universal CAR T Cells for Acute Lymphoid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

CAR T Cell Immunotherapy for Multiple Myeloma. A Review of Current Data and Potential Clinical Applications

American Journal of Hematology
Hematology
2019English

Abrogated Cryptic Activation of Lentiviral Transfer Vectors

Scientific Reports
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy